Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-004893

Chief Financial Officer sold 4,000 shares at $60.00 ($240,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Laponis Adam · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-17 Sale : show line 1 in the form 10b5-1 −4,000 $60.00 $240,000 118,694 D
Open-market sales · 4,000 sh · avg $60.00 · $240,000
Loading xslF345X06/marketforms-72950.xml…